Quantcast
Channel: Vijay Malik
Viewing all articles
Browse latest Browse all 168

Analysis: Granules India Limited

$
0
0
www.drvijaymalik.comhas a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Granules India Limited, a Hyderabad-based Indian integrated pharmaceutical manufacturer, which focuses on making active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosages (FD) as primary business activities.
Equity research report analysis Granules India Limited, active pharmaceutical ingredients API, pharmaceutical formulation intermediates PFI and finished dosages FD, Actus Pharma Limited, Omnichem
Read The Complete Article»

Viewing all articles
Browse latest Browse all 168

Trending Articles